Breakdown | ||||
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
36.85B | 34.46B | 33.65B | 25.23B | 25.39B | Gross Profit |
6.82B | 6.81B | 6.72B | 5.38B | 5.79B | EBIT |
5.88B | 5.69B | 5.96B | 4.94B | 4.86B | EBITDA |
8.88B | 5.48B | 6.82B | 5.70B | 6.75B | Net Income Common Stockholders |
5.76B | 4.09B | 3.75B | 2.86B | 3.13B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.13B | 4.24B | 4.05B | 5.30B | 2.36B | Total Assets |
55.00B | 53.67B | 52.05B | 54.08B | 49.93B | Total Debt |
10.26B | 10.94B | 11.61B | 15.25B | 15.06B | Net Debt |
8.73B | 9.49B | 10.78B | 13.57B | 14.53B | Total Liabilities |
30.34B | 31.89B | 32.58B | 36.60B | 34.87B | Stockholders Equity |
22.79B | 21.78B | 19.46B | 17.47B | 15.05B |
Cash Flow | Free Cash Flow | |||
5.38B | 6.32B | 3.45B | 8.43B | 109.00M | Operating Cash Flow |
6.64B | 6.61B | 3.69B | 8.61B | 2.04B | Investing Cash Flow |
-3.97B | -3.21B | 1.37B | -5.08B | -1.19B | Financing Cash Flow |
-2.58B | -2.79B | -5.91B | -2.39B | -1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | $5.98B | 4.12 | 28.91% | 10.08% | -0.03% | 14.25% | |
77 Outperform | $5.95B | 11.70 | 9.47% | 5.07% | -4.45% | 9.86% | |
77 Outperform | $5.95B | 10.55 | 9.47% | 5.12% | -4.45% | 9.86% | |
68 Neutral | $49.20B | 17.09 | 9.55% | 3.32% | -18.00% | -7.54% | |
63 Neutral | $8.48B | 11.84 | 5.32% | 4.35% | 3.04% | -11.46% | |
54 Neutral | $20.19B | 2,867.59 | 0.47% | 5.31% | 12.40% | -108.27% | |
52 Neutral | $7.25B | 4.30 | 29.79% | 6.81% | -3.14% | 563.59% |